Chest
-
Sleep PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: AIMS 1-To study the effect of the growth pattern in the treatment of SAHS by a MAD by the use of polysomnographic recordings. 2-To determine the effect of the growth pattern on the position of the hyoid bone in the SAHS treatment by a MAD. ⋯ The following authors have nothing to disclose: Rafael Ecija, Javier Jareño, Alejandro Coca, Inmaculada Sierra, Marta Dominguez, Carlos Gutierrez OrtegaNo Product/Research Disclosure Information.
-
Cardiovascular Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMPURPOSE: Primary pulmonary hypertension is severe and progressive disease with incidence of 1-2 cases / million / annum. Without treatment, survival is 2-3 years. Only 10% survive for 10 years. Co-existence of PPH with Marfanoid Habitus has not been reported till date in any literature or case study.Large series of 120 PPH patients from Mayo clinic by Fuster et al showed thrombotic mechanism by microemboli and plexogenic arteriopathy due to hyper reactive pulmonary arteries by open lung biopsies. ⋯ The following authors have nothing to disclose: Ram k Chopra, Sanesh Garde, Chintan Patel, Dhiraj Jain, Omkar Kajale, Rahul JalanNo Product/Research Disclosure Information.
-
Pulmonary Hypertension Posters IISESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Despite the availability of specific treatment, pulmonary arterial hypertension (PAH) remains a devastating and fatal disease. Slovakia has a systemic program of PAH management. Mortality data, however, have been lacking. The aim was to describe the survival in pts with newly diagnosed PAH at a referral centre in Slovakia in the era of targeted treatment and analyse causes of death. ⋯ The following authors have nothing to disclose: Milan Luknar, Branislav Liska, Peter Lesny, Ivan Varga, Peter Solik, Eva GoncalvesovaNo Product/Research Disclosure Information.
-
Symptoms of Respiratory Disease PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To illustrate the value of serial ventilatory and glottic responses to incremental exercise until voluntary exhaustion in an adolescent with exertional dyspnea and stridor before and after supraglottoplasty. ⋯ The following authors have nothing to disclose: Diana Orbelo, Shelagh Cofer, Paolo PianosiNo Product/Research Disclosure Information.
-
Infectious Diseases CasesSESSION TYPE: Case ReportsPRESENTED ON: Saturday, March 22, 2014 at 04:15 PM - 05:15 PMINTRODUCTION: Daptomycin is a semisynthetic lipopeptide antibiotic, the first to be marketed, used to treat gram-positive bacterial infections, specifically skin and soft tissue infections or Staphylococcus aureus bacteremia and right-sided endocarditis. Although it cannot be used in the treatment of pneumonia, due to inactivation by pulmonary surfactant, in isolated cases it has been associated with life-threatening eosinophilic pneumonia. The majority of reported cases have high levels of serum eosinophilia. We report a case of daptomycin induced eosinophilic pneumonia without elevated serum eosinophilia. ⋯ In those patients whom daptomycin is used, we must be aware of potentially life threatening daptomycin induced lung disease, even in the absence of eosinophilia. Immediate recognition is vital as discontinuation of the offending agent alone can quickly resolve the lung disease.Reference #1: Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports. Kim PW, et al. Drug Saf. 2012 Jun 1;35Reference #2: Package insert. Cubicin (daptomycin). Lexington, MA: Cubist Pharmaceuticals. Aug 2010DISCLOSURE: The following authors have nothing to disclose: Anita Rajagopal, Edward Mintz, Lindsey ReeseNo Product/Research Disclosure Information.